Weekly Recap | Editas Medicine -16.41%, consensus target above spotWeekly Review·2 days ago, 08:10 AMEDIT+1.48%
Weekly Recap | Caris Life Sciences -2.91%, most brokers rate it buyWeekly Review·2 days ago, 07:49 AMCAI+7.03%
Weekly Recap | Twist Bioscience +2%, consensus target below spotWeekly Review·2 days ago, 07:00 AMTWST+5.92%
Weekly Recap | Sellas Life Sciences -16.7%, Friday's heavy-volume slideWeekly Review·2 days ago, 06:47 AMSLS+1.56%
Weekly Recap | Revolution Medicines -2.98%, consensus target above spotWeekly Review·2 days ago, 06:40 AMRVMD+0.66%
Weekly Recap | Regeneron Pharma -5.59%, class action deadline passesWeekly Review·2 days ago, 06:39 AMREGN+1.57%
Weekly Recap | Larimar Therapeutics +2.35%, most brokers rate it buyWeekly Review·Sep 12 at 06:12 AMLRMR-3.57%
